Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerogenic dendritic cell therapy in type 1 diabetes
NL-OMON60366Phase 2Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2024
- Countries
- 1
01
Overview
Phase 2, single-arm trial in diabetes mellitus type 1 (T1D), sponsored by Leiden University Medical Center. Primary endpoint: Primary endpoint(s). Started Dec 2024; status: recruiting.
02
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON60366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60366.